Project Grant R01EB039067
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded the Trustees of Boston University a Project Grant of $613,124 under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) for the period August 15, 2025, through July 31, 2028. The project delivers the development and demonstration of Quantitative Phase Imaging Meta-Sensors (PIMSs)—advanced optical imaging sensors that...
- Federal Grant Award Summary The University of Miami received a $1.28M Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), with an award date of August 1, 2025 and completion deadline of April 30, 2029. This research initiative will develop and validate magnetic particle imaging (MPI) technology for quantitative, non-invasive monitoring of...
- Federal Project Grant Award Summary Objective Biotechnology, Inc., a Minneapolis-based minority-owned biotechnology firm, received a $416,925 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Research Infrastructure Programs (CFDA 93.351) on September 15, 2025, with an ultimate completion date of August 31, 2027. The grant supports the development and commercialization of the mini-mscope, a miniaturized imaging device designed for mesoscale...
- Federal Project Grant Award Summary Funding Agency and Program: National Institute of Biomedical Imaging and Bioengineering (NIBIB), Discovery and Applied Research for Technological Innovations to Improve Human Health (CFDA 93.286) Award Details: Georgia TECH Research Corp was awarded $603,818 on April 1, 2026, to develop and demonstrate a combined intravascular ultrasound (IVUS) and fractional flow reserve (FFR) microcatheter system. The project, which extends through March 1, 2030, addresses a...
- Federal Project Grant Award Summary Purdue University received a $375,337 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) for the period July 1, 2025 through June 30, 2027. The award funds development of fluorescence-detected photothermal infrared (F-PTIR) microscopy technology designed to track intracellular messenger RNA (mRNA)...
- Federal Project Grant Award Summary Florida International University received a $442,106 Project Grant from the National Science Foundation (NSF) Division of Chemical, Bioengineering, Environmental, and Transport Systems (CFDA 47.041 - Engineering program) effective May 15, 2025, through April 30, 2028. The award funds development of an ultrasensitive, label-free electrical detection method for small molecules using glass nanopipettes, a type of solid-state nanopore biosensor. The research...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Washington University in St. Louis a $469,585 Project Grant on August 1, 2025, under CFDA 93.286 (Discovery and Applied Research for Technological Innovations to Improve Human Health) to develop a wearable, artificial intelligence-integrated multimodal uterine monitoring system. The primary deliverable is an innovative biosensing platform designed to address significant limitations in...
- Federal Project Grant Award Summary The University of Florida, in collaboration with Clemson University, received a $616,523 Project Grant award dated August 8, 2025, from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The project, which concludes July 31, 2028, develops a generative artificial intelligence (AI)-driven platform for cell morphology-guided,...
- Federal Project Grant Award Summary Florida State University received a $432,800 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 20, 2025, with completion targeted for August 31, 2027. The project develops a centrifugal microfluidic system that enables real-time, parallel measurement of secretion dynamics from individual spheroids and organoids—three-dimensional,...
- Federal Project Grant Award Summary Duke University received a $722,392 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under CFDA 93.286, Discovery and Applied Research for Technological Innovations to Improve Human Health, awarded March 10, 2026, with completion targeted for February 28, 2030. The project involves developing 4D Smart Epidermal Photoacoustic Tomography (4D-SEPAT), a real-time, longitudinal functional brain imaging technology designed...
Florida International University received a $327,769 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), awarded June 2, 2026, with a completion date of March 31, 2030. The award supports development of a label-free, polarization-sensitive optical imaging probe designed to non-invasively assess cervical remodeling during pregnancy. The deliverables include a miniaturized optical probe capable of delivering high-resolution polarization-sensitive second harmonic generation and two-photon fluorescence microscopy imaging of the uterine cervix in vivo, with specific focus on quantifying cervical collagen changes and molecular content alterations associated with preterm birth risk. The project encompasses three specific research objectives: developing the miniaturized optical probe technology (Aim 1), conducting longitudinal in vivo imaging studies using an animal model across the pregnancy cycle and postpartum period (Aim 2), and characterizing cervical remodeling in two preterm birth models using lipopolysaccharide and mifepristone interventions (Aim 3). This technology development aims to provide the first complete method for visualizing and quantifying cervical extracellular matrix changes during pregnancy, addressing a significant gap in current clinical capabilities for predicting preterm birth onset.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $327.8k | 6/3/26 |